[Bacteriological evolution established in 406 tuberculosis patients treated with various combinations with or without rifampicin or INH].
D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D007538:Isoniazid; D012293:Rifampin
Evolution bactériologique constatée chez 406 tuberculeux pulmonaires traités par des associations diverses comprenant ou non la rifampicine ou l'INH.